Switzerland's medical technology industry is having a strange kind of year. By almost every headline measure, it is thriving: output is expanding at twice the rate of the broader Swiss economy, exports are climbing, and research spending remains among the highest of any industrial sector in the country. Yet beneath those numbers, the people who run the country's medtech companies are sounding an alarm that has been building for several years and has now become impossible to i